Latest filing published 01 Apr 2019 for Avalo Therapeutics, Inc., €10k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Uli Hacksell: trading record in brief
Uli Hacksell discloses dealings in 2 companies, chiefly Acadia Pharmaceuticals Inc and Avalo Therapeutics, Inc. We count 122 filings; the first trade dates from 8 August 2006 and the latest from 9 June 2017.
On the open market, the record shows 2 purchases worth €14k and 46 sales worth €9.3M. Taken together, the sales exceed the purchases by €9.2M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 24 option exercises. In 2019 alone, the filings show 2 purchases and no sales.
The newest entry dates from 1 April 2019: an open-market purchase of €10k, in Avalo Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Uli Hacksell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$1.07Common StockSEC:0001578563-19-000008:0Canonical exit: 10 Mar 2017 (T+90)
- 10,000 shares@ US$0.42Common StockSEC:0001578563-19-000008:1Canonical exit: 7 Sept 2017 (T+90)
- 30,000 shares@ US$1.55Common StockSEC:0001415889-15-000614:0
- 30,000 shares0Common StockSEC:0001415889-15-000614:1
- 30,000 shares0Common StockSEC:0001415889-15-000614:2
- 30,000 shares@ US$34.30Common StockSEC:0001415889-15-000614:3
- 30,000 shares@ US$2.00Common StockSEC:0001415889-15-000169:0
- 30,000 shares0Common StockSEC:0001415889-15-000169:1
- 30,000 shares0Common StockSEC:0001415889-15-000169:2
- 30,000 shares@ US$33.98Common StockSEC:0001415889-15-000169:3
- 30,000 shares@ US$2.00Common StockSEC:0001415889-14-003915:0
- 30,000 shares0Common StockSEC:0001415889-14-003915:1
- 30,000 shares0Common StockSEC:0001415889-14-003915:2
- 30,000 shares@ US$31.00Common StockSEC:0001415889-14-003915:3
- 30,000 shares@ US$2.00Common StockSEC:0001415889-14-003735:0
- 30,000 shares0Common StockSEC:0001415889-14-003735:1
- 30,000 shares0Common StockSEC:0001415889-14-003735:2
- 30,000 shares@ US$29.28Common StockSEC:0001415889-14-003735:3
- 30,000 shares@ US$2.00Common StockSEC:0001415889-14-003050:0
- 30,000 shares0Common StockSEC:0001415889-14-003050:1
- 30,000 shares0Common StockSEC:0001415889-14-003050:2
- 30,000 shares@ US$24.15Common StockSEC:0001415889-14-003050:3
- 30,000 shares@ US$2.00Common StockSEC:0001415889-14-002797:0
- 30,000 shares0Common StockSEC:0001415889-14-002797:1
- 30,000 shares0Common StockSEC:0001415889-14-002797:2
25 of 122 declarations
